Related Experiment Video
Updated: Jul 5, 2025
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Global retinoblastoma studies: A review
Vijitha S Vempuluru1, Arpita Maniar2, Swathi Kaliki1
1The Operation Eyesight Universal Institute for Eye Cancer, L V Prasad Eye Institute, Hyderabad, India.
Insights
Global studies on retinoblastoma (RB) reveal disparities in care, particularly for children in underdeveloped nations. Insights from these studies can improve global health strategies and inform policy for better RB outcomes worldwide.
Area of Science:
- Ophthalmology
- Global Health
- Pediatric Oncology
Background:
- Retinoblastoma (RB) care presents significant challenges in underdeveloped nations.
- Global health awareness necessitates understanding international similarities and disparities in RB management.
- Collaborative global studies are crucial for generating robust evidence on retinoblastoma.
Purpose of the Study:
- To review insights from global retinoblastoma studies.
- To highlight disparities in RB care based on national income levels.
- To inform policy reforms and improve individual practice in retinoblastoma management.
Main Methods:
- Review of global collaborative studies on retinoblastoma.
- Analysis of data on demographics, epidemiology, and clinical presentations.
- Examination of management protocols, pathology, treatment outcomes, and the impact of COVID-19.
Main Results:
- Global RB studies provide insights into demographics, epidemiology, and etiopathogenesis.
- Significant disparities exist in clinical presentations and management based on national income.
- The COVID-19 pandemic has impacted retinoblastoma care globally.
Conclusions:
- Understanding global retinoblastoma insights is vital for equitable care.
- Addressing disparities can lead to comparable outcomes for affected children worldwide.
- These findings can guide policy reforms and enhance clinical practice for retinoblastoma.
Abstract:
In the current era of global health awareness for retinoblastoma (RB), the challenge that lies ahead of us is providing optimal care for children affected with RB in underdeveloped nations. The understanding of similarities and disparities between various nations across the world aids in achieving comparable outcomes. With dissolving geographic barriers and evolving collaboration, global collaborative studies on RB are becoming increasingly common. They provide real-world, robust evidence on several aspects of RB. This review discusses insights gained from global RB studies regarding the demographics, certain aspects of etiopathogenesis and epidemiology, international travel burden, disparities in clinical presentations based on national income levels, management protocols, pathology, treatment outcomes, and the effect of COVID-19 on RB care across the world. These insights are likely to impact individual practice as well as inform policy reforms.
